At a glance
- Originator NeuroSearch
- Class Anti-ischaemics; Muscle relaxants; Phenylurea compounds; Small molecules
- Mechanism of Action Potassium channel agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Coronary disorders
Most Recent Events
- 28 Mar 2000 No-Development-Reported for Coronary disorders in USA (Unknown route)
- 15 Feb 1996 Preclinical development for Coronary disorders in USA (Unknown route)